Results 201 to 210 of about 289,700 (218)

Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis. [PDF]

Arthritis Res Ther
van Wesemael TJ, Morton FR, Heutz JW, Maurits MP, Dorjée AL, Porter D, Huizinga TWJ, Raza K, Toes REM, Knevel R, de Jong PHP, Svärd A, van der Woude D.   +12 more
europepmc   +1 more source

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

, 2015
Daniel D. Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus, Deborah Wentworth, Margaret Johnson, Michael J. Vjecha, Anthony D. Kelleher, Sean Emery   +9 more
openalex   +2 more sources

COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly. [PDF]

Vaccines (Basel)
Berber E, Pantouli F, Hanley HB, Ross TM.   +3 more
europepmc   +1 more source

Self-assembled epitope-based nanoparticles targeting the SARS-CoV-2 spike protein enhanced the immune response and induced potential broad neutralizing activity. [PDF]

Front Cell Infect Microbiol
Liu Y, Li C, Wu Z, Zhao Y, Yin T, Liu X, Hui J, Wang Q, Pan Y, Shan Y, Qu X.   +10 more
europepmc   +1 more source

An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against <i>Acinetobacter baumannii</i> Infection. [PDF]

Vaccines (Basel)
Jeffreys S, Aki J, Tompkins MP, Prather ND, Murthy AK, Chambers JP, Guentzel MN, Hung CY, Arulanandam BP, Yu JJ.   +9 more
europepmc   +1 more source

Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19. [PDF]

Front Immunol
Yang X, Tang X, Sun Y, Xi H, Peng W, Yan L, Teng W, Zang Y, Jiang C.   +8 more
europepmc   +1 more source

Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2⁺ and TNBC) Cells-A Proof of Principle Investigation. [PDF]

Int J Mol Sci
Chen IP, Henning S, Bender M, Degenhardt S, Mhamdi Ghodbani M, Bergmann AK, Volkmer B, Brockhoff G, Wege AK, Greinert R.   +9 more
europepmc   +1 more source

Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community. [PDF]

Int J Mol Sci
Kalimba EM, Noukimi SF, Mbonimpa JB, Shintouo CM, Ouali R, Diallo MT, Vicario A, Vandecasteele S, Nchang AS, Shinyuy LM, Efeti MT, Nsengiyumva Ishimwe AN, Biryuwenze AB, Habimana AM, Mugisha LMFN, Ayadi S, Shey RA, Njemini R, Ghogomu SM, Souopgui J.   +19 more
europepmc   +1 more source

Development and validation of a blocking ELISA for measurement of rabies virus neutralizing antibody. [PDF]

J Clin Microbiol
Xiao Y, Wu M, Xu W, Sun S, Liu T, Liu Y, Li H, Feng N, Tu C, Feng Y.   +9 more
europepmc   +1 more source

Membrane-targeted immunogenic compositions using exosome mimetic approach for vaccine development against SARS-CoV-2 and other pathogens. [PDF]

Sci Rep
Sahin F, Atasoy BT, Yalcin S, Bitirim VC.   +3 more
europepmc   +1 more source